Nasdaq GlobeNewswire

Ballast Point Brewing to Open in Downtown Disney® District at the Disneyland® Resort

Del

Award-winning Southern California craft brewer to open in late 2018 with a restaurant, brewery and beer garden

Opening marks Downtown Disney® District's first-ever on-site brewery

SAN DIEGO, Jan. 24, 2018 (GLOBE NEWSWIRE) -- San Diego-based Ballast Point®, a pioneer in the craft beer industry and one of the nation's leading craft breweries known for high-quality, award-winning and innovative beers, today announced the opening of a brewery, tasting room and kitchen in the Downtown Disney® District at the Disneyland® Resort. The opening marks the first-ever brewery for Downtown Disney. Opening in late 2018, the 7,000-sq. ft. space will house a three-barrel "research and development" brewery, New American restaurant and outdoor beer garden. This will be Ballast Point's first location in Orange County and seventh in Southern California.

"As one of Southern California's premier brewers, for the team at Ballast Point, we couldn't be more honored to work with such an icon in our great state and become the first brewer at Downtown Disney," said Marty Birkel, president of Ballast Point Brewing Company. "We hope SoCal locals and visitors alike will enjoy the wonderful atmosphere, seasonal cuisine, and good cheer (and beer) of our signature tap room experience that we plan to bring to Disney."
"We are thrilled to welcome Ballast Point to Downtown Disney," said Patrick Finnegan, vice president of Disney California Adventure and Downtown Disney. "Our guests are constantly asking for new and innovative dining experiences, and Ballast Point's selection of award-winning beers, locally inspired cuisine and friendly atmosphere make them a perfect fit."

Along with its beers, the restaurant's menu will also offer a taste of San Diego with some of its most popular dishes from its brew pubs, including Baja-style fish tacos and a house-made pretzel with beer mustard. Similar to Ballast Point's brewing philosophy, the kitchen will only source the best possible ingredients, including steroid and antibiotic-free proteins, line-caught fish and local produce when available. The kitchen will feature a seasonally inspired menu, with a focus on cuisine that not only pairs well with the vast selection of beers, but incorporates them in the recipes. The location will also offer a children's menu, along with gluten-free and vegetarian options for guests.

The location will be family-friendly, offering an outdoor patio and large-party, cabana style seating, and visitors 21+ can enjoy many of Ballast Point's iconic beers including its flagship and award-winning Sculpin® IPA, as well as exclusive, custom, limited-edition beers available only at the Downtown Disney location. Known for its unrelenting commitment to quality, unique flavor profiles and a desire to bring great tasting beer to consumers across the country, Ballast Point has been dedicated to the craft of brewing for more than 20 years.

The new Downtown Disney location further extends Ballast Point's brand presence in Southern California and will introduce its quality, great-tasting beer to visitors from around the country and the world. Ballast Point currently operates six tasting room locations in California, including Long Beach and Little Italy in San Diego, and a new brewery and tasting room in Daleville, Virginia. Coming soon, the brewer will also open a brewery and kitchen in Chicago - its first in the Midwest.

About Ballast Point 
What started in 1996 as a small group of home brewers who simply wanted to make great beer evolved into the team of adventurers known today as Ballast Point. From bringing a hoppy twist to a porter, or adding four types of malt to its amber ale, to creating the breakthrough gold-medal winning Sculpin IPA, the San Diego-based company is known for adding its own touch and asking if there's a better way. Now an internationally recognized leader in the craft brewing industry with 7 brewery locations in California and Virginia, the company makes over 50 styles of beer and distributes to 49 states and 17 countries internationally. For more information, visit www.ballastpoint.com.

About Constellation Brands
Constellation Brands (NYSE:STZ) (NYSE:STZ.B), a Fortune 500® company, is a leading international producer and marketer of beer, wine and spirits with operations in the U.S., Mexico, New Zealand, Italy and Canada. Constellation is the No. 3 beer company in the U.S. with high-end, iconic imported brands such as Corona Extra, Corona Light, Modelo Especial, Modelo Negra and Pacifico. The company's beer portfolio also includes Ballast Point, one of the most awarded craft brewers in the U.S. In addition, Constellation is the world leader in premium wine, selling great brands that people love, including Robert Mondavi, Clos du Bois, Kim Crawford, Meiomi, Mark West, Franciscan Estate, Ruffino and The Prisoner. The company's premium spirits brands include SVEDKA Vodka, Casa Noble Tequila and High West Whiskey.

Based in Victor, N.Y., the company believes that industry leadership involves a commitment to brand building, our trade partners, the environment, our investors and to consumers around the world who choose our products when celebrating big moments or enjoying quiet ones. Founded in 1945, Constellation has grown to become a significant player in the beverage alcohol industry with more than 100 brands in its portfolio, about 40 facilities and approximately 9,000 talented employees. We express our company vision: to elevate life with every glass raised. To learn more, visit www.cbrands.com.

MEDIA CONTACT :
Jennifer Dohm
jennifer.dohm@cbrands.com

Photos accompanying this announcement are available at:
http://www.globenewswire.com/NewsRoom/AttachmentNg/09a42ba2-d176-417c-8b8b-15aa1f5fd933 
http://www.globenewswire.com/NewsRoom/AttachmentNg/0d9987f1-8726-493c-93bd-6a7c84846059 




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Constellation Brands, Inc via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Manufacturing Leadership Forum Will Highlight Enabling Industry 4.0 with Analytics25.9.2018 15:06Pressemelding

Upcoming Dates in Houston, Texas and Antwerp, Belgium PORTLAND, Ore., Sept. 25, 2018 (GLOBE NEWSWIRE) -- New dates for The Manufacturing Leadership Forum were announced today including Houston, Texas, US on October 9, 2018 at the Petroleum Club of Houston and on November 28, 2018 in Antwerp, Belgium at the Lindner WTC Hotel & City Lounge. The events are sponsored by Northwest Analytics, a leading provider of manufacturing intelligence and SPC software solutions for manufacturers. This premier manufacturing analytics educational event focuses on enabling Industry 4.0 programs with manufacturing analytics. The Forums will feature keynotes and case-study presentations from globally-recognized leaders in the application of manufacturing analytics. In its fourth year, The Manufacturing Leadership Forum will open with a keynote from analytics visionary, Dr. Lloyd Colegrove, Director of Data Services & Fundamental Problem Solving at The Dow Chemical Company. “The Manufacturing Leadership Foru

Checkpoint Therapeutics Announces Presentation of Updated Data from Phase 1/2 Trial of EGFR Inhibitor CK-10125.9.2018 14:00Pressemelding

Data were featured in an oral presentation at the IASLC 19th World Conference on Lung Cancer Phase 3 trial in treatment-naïve EGFR mutation-positive NSCLC patients targeted to commence in 2019 NEW YORK, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers, today announced that positive preliminary safety and efficacy data from an ongoing Phase 1/2 clinical trial of CK-101 were presented yesterday in an oral presentation at the International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer in Toronto. The oral presentation included further details on, and updates from, the dataset announced previously. CK-101 is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) being evaluated in advanced non

SpeeDx Begins Multisite U.S. Clinical Trials of ResistancePlus® MG Test25.9.2018 14:00Pressemelding

Test supports international guidelines for treating antibiotic resistant STI SYDNEY, Australia, Sept. 25, 2018 (GLOBE NEWSWIRE) -- SpeeDx Pty. Ltd. today announced the start of patient testing in their multisite U.S.-based clinical trials for ResistancePlus® MG (not available for sale in the U.S.). The molecular diagnostic test detects the sexually transmitted infection (STI) Mycoplasma genitalium, also known as Mgen or MG, along with genetic markers linked to antibiotic resistance. In recent years, Mgen prevalence has increased globally and developed high rates of resistance to the common antibiotic treatment, azithromycin. "This test is an exciting new development that will increase the precision of patient care for patients impacted by Mycoplasma genitalium - a common sexually transmitted infection with limited treatment options,” notes Dr Maria Trent, Professor of Pediatrics and Public Health at Johns Hopkins Medicine. The SpeeDx ResistancePlus MG test is in use in laboratories acr

Novavax Initiates Phase 2 Clinical Trial of NanoFlu™ in Older Adults25.9.2018 13:00Pressemelding

First participants enrolled in Phase 2 clinical trial of quadrivalent NanoFlu formulations Top-line immunogenicity and safety data expected in the first quarter of 2019 Phase 2 results will support meeting with the U.S. Food and Drug Administration (FDA) and Phase 3 clinical trial design GAITHERSBURG, Md., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX) today announced the initiation of a Phase 2 dose and formulation confirmation clinical trial in older adults of NanoFlu, its nanoparticle seasonal influenza vaccine candidate. “Initiating this Phase 2 clinical trial of NanoFlu is an important milestone for Novavax,” said Stanley C. Erck, President and Chief Executive Officer of Novavax. “With top-line results expected in the first quarter of 2019, we plan to discuss these data with the FDA at an ‘End of Phase 2’ meeting and to agree on the appropriate Phase 3 clinical trial design to support licensure via accelerated approval. We continue to believe NanoFlu is a differen

CGAP Launches Photo and Video Contest Theme for 2018: Financial Inclusion in Africa25.9.2018 13:00Pressemelding

This year's CGAP contest is the first ever to accept short video entries WASHINGTON, Sept. 25, 2018 (GLOBE NEWSWIRE) -- The Consultative Group to Assist the Poor’s (CGAP) 13th annual photo contest, launched today, is seeking striking images on financial inclusion in Africa. For the first time, short video submissions on Africa also will be accepted. Entries may be submitted through December 14, 2018. Each contestant may submit up to 20 photos or videos to compete for the Grand Prize worth US$ 2,000. This year CGAP is looking for original and compelling photographs and short videos that tell the story of how financial services empower poor people and communities in Africa. The region is a center for financial innovation -- home to M-Pesa, the mobile money service launched a decade ago now replicated across markets worldwide; host to vibrant FinTech and e-commerce companies; and to a growing off-grid sector that leverages digital finance. Together these innovators contribute toward lifti

Kick-starting health in the workplace25.9.2018 10:00Pressemelding

Over 800 organizations step, bike, swim and yoga their way to better health and wellbeing as the May 2018 Virgin Pulse Global Challenge Concludes ZURICH, Switzerland, Sept. 25, 2018 (GLOBE NEWSWIRE) -- On August 30th more than 270,000 people, across 144 countries, completed Virgin Pulse’s 100-day Global Challenge, moving them towards a more active, healthy and productive lifestyle. With this achievement, Virgin Pulse, an international leader in employee health and wellbeing, once again proves it’s helping to improve employee lives for good. The company’s Global Challenge event encourages exercise, mindfulness and healthy habits at work, leading to a happier culture and reduced costs to the organization. “Through increased awareness, education and motivation, employees master long-term, sustainable habits allowing them to arrive at work feeling more engaged, productive and equipped for peak performance,” says David Osborne, Chief Executive Officer of Virgin Pulse. “The follow-on effects

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom